Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesRisk factors for development of coronary artery disease in women with systemic lupus erythematosus
Journal of Rheumatology, 10/19/09
Goldberg RJ et al. – In a prospective study of patients with SLE and matched controls followed over a median of 8 years, patients with SLE developed significantly more CAD events than controls. Accounting for demographic variability, CAD risk factors, and lipid factors, SLE is an independent risk factor for the development of CAD.
Methods- SLE patients and non-SLE age-matched controls without a history of CAD recruited into prospective study between 1997 and 1999
- CAD events assessed at clinic visit for SLE patients and through telephone interview and chart review for controls
- All events verified with medical records
- Followup information available on 237 controls and 241 SLE patients
- Mean followup time was 7.2 years
- Univariate analyses identified age and postmenopausal status as predictors of CAD in both groups
- Sedentary lifestyle, hypertension, the presence of metabolic syndrome, and the number of Framingham risk factors predictive in control group only
- 10-year risk of CAD score predictive in both groups but not as marked in SLE group as in controls
- Lipid subfractions not predictive for CAD in SLE group
- In controls, high triglyceride level ≥ 2.8 predictive
- Time-to-event multivariate analysis for CAD in all subjects revealed SLE , older age, and triglycerides ≥ 2.8 to be highly predictive for CAD
Today in Systemic Lupus (SLE)...keeping you current
Receive free subspecialty "5-minute updates" via email
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Kidney International, 11/05/09
Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus. A randomized controlled trial
Annals of Rheumatic Diseases, 11/10/09
Thyroid Cancer in Systemic Lupus Erythematosus: A Case-Control Study
Journal of Clinical Endocrinology and Metabolism, 11/12/09
Sponsor
Article Search
Sponsor